2026 Lisa A. Jackson: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	97	817	747	460	414	319	36938
Medicine	97	9233	8667	4763	4405	321	36995

Overview

Lisa A. Jackson is affiliated with Kaiser Permanente in the United States. Their research focuses primarily on medical sciences, with a significant concentration in infectious diseases, epidemiology, and public health.

The scientist has contributed extensively to the field of infectious diseases, with notable involvement in SARS-CoV-2 and COVID-19 research, influenza virus studies, and vaccine research. Their work also covers broader topics related to respiratory viral infections, vaccine coverage and hesitancy, and viral gastroenteritis epidemiology. Animal virus infections also appear among their areas of study.

Lisa A. Jackson's publication record includes contributions to several key scientific journals. Frequent publication venues include:

Vaccine
Clinical Infectious Diseases
bioRxiv (Cold Spring Harbor Laboratory)
New England Journal of Medicine
Open Forum Infectious Diseases

Among recent papers, notable publications feature titles such as:

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report (2020, New England Journal of Medicine)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (2020, New England Journal of Medicine)
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination (2020, New England Journal of Medicine)
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 (2021, New England Journal of Medicine)
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase (2021, New England Journal of Medicine)

Frequent co-authors collaborating with Lisa A. Jackson include:

Matthew F. Daley
Edward A. Belongia
Paul C. Roberts
Nadine Rouphael
Nicola P. Klein

Their research spans several subfields, including:

Infectious Diseases
Epidemiology
Health
Public Health, Environmental and Occupational Health
Immunology

The main fields of study for Lisa A. Jackson are centered in medicine, with a total of over 230 publications. Their scientific contributions provide data and insights across multiple significant public health topics, particularly focusing on viral infectious diseases and vaccine-related research.

Best Publications

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Lisa A. Jackson;Evan J. Anderson;Nadine G. Rouphael;Paul C. Roberts

3419
Citations
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

1560
Citations
Chlamydia pneumoniae (TWAR)

Cho-Chou Kuo;L. A. Jackson;L. A. Campbell;J. T. Grayston

1184
Citations
Homologous and Heterologous Covid-19 Booster Vaccinations

Unknown

945
Citations
Effectiveness of pneumococcal polysaccharide vaccine in older adults.

Lisa A. Jackson;Kathleen M. Neuzil;Onchee Yu;Patti Benson

829
Citations
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

Alicia T. Widge;Nadine G. Rouphael;Lisa A. Jackson;Evan J. Anderson

799
Citations
Standardizing Chlamydia pneumoniae assays : Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada)

Scott F. Dowell;Rosanna W. Peeling;Jens Boman;George M. Carlone

752
Citations
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.

Lone Simonsen;Lone Simonsen;Robert J Taylor;Cecile Viboud;Mark A Miller

706
Citations
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.

Nicole Doria-Rose;Mehul S. Suthar;Mat Makowski;Sarah O’Connell

672
Citations
Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

D. Rebecca Prevots;Pamela A. Shaw;Daniel Strickland;Lisa A. Jackson

665
Citations
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.

Kristin L. Nichol;Paul M. Mendelman;Kenneth P. Mallon;Lisa A. Jackson

627
Citations
Evidence of bias in estimates of influenza vaccine effectiveness in seniors

Lisa A Jackson;Michael L Jackson;Jennifer C Nelson;Kathleen M Neuzil

590
Citations
Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants: A Randomized Clinical Trial

Flor M. Munoz;Nanette H. Bond;Maurizio Maccato;Phillip Pinell

566
Citations
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.

Hana M El Sahly;Lindsey R Baden;Brandon Essink;Susanne Doblecki-Lewis

566
Citations
The Burden of Community-Acquired Pneumonia in Seniors: Results of a Population-Based Study

Michael L. Jackson;Kathleen M. Neuzil;Kathleen M. Neuzil;William W. Thompson;David K. Shay

551
Citations
Azithromycin for the Secondary Prevention of Coronary Events

J. Thomas Grayston;Richard A. Kronmal;Lisa A. Jackson;Alfred F. Parisi

514
Citations
Risk of anaphylaxis after vaccination in children and adults

Michael M. McNeil;Eric S. Weintraub;Jonathan Duffy;Lakshmi Sukumaran

442
Citations
Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

Suzanne E. Ohmit;Mark G. Thompson;Joshua G. Petrie;Swathi N. Thaker

406
Citations
Early Thimerosal Exposure and Neuropsychological Outcomes at 7 to 10 Years

William W. Thompson;Barbara Goodson;David K. Shay;Patti Benson

391
Citations
Cat scratch disease in the United States: an analysis of three national databases.

L A Jackson;B A Perkins;J D Wenger

387
Citations
Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Commentary

Lisa A. Jackson;Michael L. Jackson;Jennifer C. Nelson;Kathleen M. Neuzil

4
Citations

Frequent Co-Authors

Edward A. Belongia Marshfield Clinic

Manjusha Gaglani Baylor College of Medicine

Richard K. Zimmerman University of Pittsburgh

Huong Q. McLean Marshfield Clinic

Brendan Flannery Centers for Disease Control and Prevention

Arnold S. Monto University of Michigan–Ann Arbor

Mary Patricia Nowalk University of Pittsburgh

Alicia M. Fry Emory University

Nicola P. Klein Kaiser Permanente

Allison L. Naleway Kaiser Permanente

External Links

Personal website of Lisa A. Jackson

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with nursing and healthcare fields, where advanced education can unlock diverse opportunities. For Registered Nurses aiming to specialize further, exploring an fnp to acnp bridge program online offers a streamlined path to Acute Care Nurse Practitioner roles, blending clinical expertise with immunological understanding.

For those transitioning from registered nurses to nurse practitioners, accelerated options exist. The accelerated rn to np programs are specifically designed for efficiency, enabling healthcare professionals to quickly gain advanced practice credentials relevant to immunology-centered care.

If you’re new to nursing but interested in immunology, there are flexible pathways as well. Online RN programs for non nurses can provide foundational clinical training without prior experience. The online rn programs for non nurses are ideal for career changers eager to enter healthcare with a focus on immunologic principles.

Additionally, if you’re looking for quicker entry into nursing, some of the easiest accelerated nursing programs offer accessible admission criteria and condensed coursework to jumpstart clinical practice environments that complement immunology research and patient care.